ONF:哪种戒烟手册对肺癌患者家属戒烟效果棒棒哒?

2015-07-04 MedSci MedSci原创

目的:该研究的目的在于探索创新出一种具有性别特异性、且可以通过情感抚慰和亲情教育等相关因素,进而起到鼓励肺癌患者的相关家属成功戒烟的效果。方式:该研究为定性、描述性研究。实验地点在加拿大六个城市进行,参与人员为30名准备近期戒烟、或已经成功戒烟的肺癌患者的家属。这种戒烟手册通过采用语言和图片的形式强调家庭成员及亲属关系的重要性,并且根据戒烟者性别的不同而进行不同的讨论和指导,从而鼓励肺癌患者家属戒

目的:
该研究的目的在于探索创新出一种具有性别特异性、且可以通过情感抚慰和亲情教育等相关因素,进而起到鼓励肺癌患者的相关家属成功戒烟的效果。


方式:
该研究为定性、描述性研究。实验地点在加拿大六个城市进行,参与人员为30名准备近期戒烟、或已经成功戒烟的肺癌患者的家属。这种戒烟手册通过采用语言和图片的形式强调家庭成员及亲属关系的重要性,并且根据戒烟者性别的不同而进行不同的讨论和指导,从而鼓励肺癌患者家属戒烟。研究者依据参与人员的性别给予不同的戒烟手册,之后采用半结构式电话访谈,让他们描述出阅读完手册后的想法并且得到的感悟,并针对他们的访谈结果进行主题分析。

结果:
通过研究得出参与人员的三个主要观点:1.这种戒烟手册十分新颖:将患者的家庭关系及亲情作为宣教重点;2.引起对戒烟的思考:思考如何才是让患者家属下定戒烟决心的真正动机;3.戒烟与性别的关联:通过不同类别的戒烟手册,戒烟者会对自身情况有了更深的了解。尽管参与人员提出了鼓励患者戒烟的其他重要的原因,但是研究结果表明,家庭关系及亲情是鼓励患者戒烟的最重要动机。大多数参与人员都认为这种因性别不同而不同的戒烟手册在各种医疗机构可以得到普及,得到广大民众的认可。

结论:
该研究将戒烟的宣教重点放在肺癌患者家属的家庭关系和亲情教育,通过这种方式研究出的戒烟手册,戒烟的效果更好。

对护理的启迪:
若想让肺癌患者的家属成功戒烟,我们应将研究重点置于从他们的家庭关系和亲情教育出发,打情感牌,这对他们成功戒烟可以起到积极的作用。

原始出处:
Joan L. BottorffCarole A. RobinsonGayl Sarbit
Raquel B. GrahamMary T. KellyIris Torchalla.https://onf.ons.org/onf/42/4-1/motivational-gender-sensitive-smoking-cessation-resource-family-members-patients-%E2%80%A8with

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (41)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-08 huaxipanxing

    看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-07 famous

    还好!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-07 famous

    还好!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-07 famous

    还好!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-07 famous

    还好!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-07 famous

    还好!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-07 famous

    还好!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1948029, encodeId=e408194802975, content=<a href='/topic/show?id=3eb75302455' target=_blank style='color:#2F92EE;'>#患者家属#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53024, encryptionId=3eb75302455, topicName=患者家属)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLIQxicGuURvblbKDmmdLreAdrFKYA57y7viabog6mfk8dXQpQzYCf0ibcgoMnFrQ2MiaV8Iic4ocdhEfw/132, createdBy=0e3a2500177, createdName=ms1692810954239974, createdTime=Fri Oct 02 08:51:00 CST 2015, time=2015-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990546, encodeId=9182199054676, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82222, encryptionId=5739822223f, topicName=肺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Sun Mar 20 14:51:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31668, encodeId=4bc03166822, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:37:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31049, encodeId=6d5231049d2, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:41:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31040, encodeId=afc7310403f, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31033, encodeId=f6113103328, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31039, encodeId=97153103941, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31038, encodeId=46063103851, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31037, encodeId=c87d3103eb0, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31034, encodeId=0e60310344e, content=还好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e880105337, createdName=famous, createdTime=Tue Jul 07 07:40:00 CST 2015, time=2015-07-07, status=1, ipAttribution=)]
    2015-07-07 famous

    还好!

    0

相关资讯

BBC:肺癌治疗的里程碑新发现

2015年5月30日,据BBC新闻报道的一项新近研究称,肺癌治疗可使一些患者的生存期加倍,实属里程碑式的新发现。        Nivolumab可使隐藏与人体正常防御系统之下的癌细胞无所遁形,让其接受人体免疫系统的自发处理。        该结果来自纳入582例癌症患者的研究结论,在美国临床肿瘤学

ACS指南:所有肺腺癌患者都需基因检测

ASCO最近认可了一项指南,确定了哪些肺癌患者需要进行基因检测测试评估,最显著的是陈述了所有的肺腺癌(或具有肺腺癌成分的混合肺癌)患者都应该接受表皮生长因子受体(EGFR)和间变性淋巴瘤激酶(ALK)的检测。无论患者的性别、种族和吸烟习惯如何都应该进行上述测试。因为基因检测能帮助制定针对肺癌患者的个体化的治疗方案,并且改善晚期肺癌患者的预后”。因为EGFR靶向药物如厄罗替尼和阿法替尼,ALK靶向药

PNAS:携带siRNA纳米颗粒可抑制肺癌细胞

RNA干扰(RNAi)是一种很有前途的方法,可以用来作为针对人体不同疾病(如癌症)的治疗策略。然而,在体内,如何将小分子siRNA转移到肿瘤或者癌细胞聚集的区域一直是很难的课题。通过一种高效的自组装系统,来自美国哈佛医学院和中国四川大学华西医学院的课题组,发展了一套独特的纳米颗粒平台,通过由固体多聚阳离子脂类和脂类-多聚乙二醇构成的分子外壳,包裹着小分子siRNA的运输系统。 在465个非小细胞

ONF:与性别相关的健康教育手册促使肺癌患者戒烟效果更好

目的:该研究的目的在于收集一种通过革新且与性别相关的宣传教育手册的有效性,该手册采用情感激励手段及其相关因素用于鼓励肺癌病人戒烟。方式:该研究为定性、描述性研究。实验在加拿大六个城市进行。参与人员为30个近期戒烟的肺癌患者。我们使用宣传手册分别对男性和女性患者用交谈和图片教育进行宣传教育,强调家庭成员的作用和他们的性别反思,使他们具有戒烟的勇气和信心,起到激励的作用。我们分别给男性和女性肺癌患者予

美国医院肺癌放疗全新技术

什么是放疗治疗?  放疗治疗是一个医疗过程,用高能量的放射线杀死肿瘤细胞,并缩小肿瘤。  放疗是如何起作用的?  高能射线破坏细胞中的DNA,导致他们死亡或停止分裂。因此癌细胞比正常细胞分裂更快,他们更加容易被破坏,更易受到攻击。健康细胞也会受到影响,但是能够更好的修复这种破坏。  什么时候适合使用放疗?  小细胞肺癌和非小细胞肺癌经常用放疗进行治疗,放疗经常与化疗,或外科手术,或者两者一起,联合

EMBO Mol Med:小分子药物治疗肺癌新突破

一个由约翰霍普金斯研究员Venu Raman博士领导的多学科小组协同约翰霍普金斯大学的Guus Bol、Farhad Vesuna及Phuoc Tran共同研发出针对世界第一大癌症——肺癌的一个新疗法。该治疗方法的研发工作历时六年,研究团队设计出一种划时代的分子药物。该分子RK-33能够阻断肺癌细胞的细胞周期而不损伤正常细胞,并且在单用以及联合放疗中显示是有效的。该团队设计了能够与DDX3结合的分